Načítá se...
Low Dose Naltrexone and Lung Cancer: A Case Report and Discussion
Low dose naltrexone (LDN) has been promising as a complementary medication for patients with a broad range of medical disorders. Although not a proven cure, evidence from clinical trials supports LDN as being a valuable adjunct for disorders in which the immune system plays a centralized role. Addit...
Uloženo v:
| Vydáno v: | Cureus |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Cureus
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6126779/ https://ncbi.nlm.nih.gov/pubmed/30197847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.2924 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|